Location: Larkspur, CA
CIK: 0001425738 · Show all filings
Period: Q1 2026 (← Previous)
Filing Date: May 15, 2026
Total Value: $1.51B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | 173,859 | $9.821M | 0.7% | $58.72 | 0.0% | COM | 09061G101 |
| PRME | PRIME MEDICINE INC | 1,590,832 | $5.536M | 0.4% | $3.80 | 0.0% | COM | 74168J101 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 700,000 | $5.068M | 0.3% | $8.37 | 0.0% | COM | 29842P105 |
| ARDX | ARDELYX INC | 733,350 | $4.393M | 0.3% | $7.08 | 0.0% | COM | 039697107 |
| AGMB | AGOMAB THERAPEUTICS NV | 156,250 | $1.639M | 0.1% | $10.49 | — | SPONSORED ADS | 00860C102 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP | 9,066,621 (+73.7%) | $446M (+93.8%) | 29.5% | $29.98 | +51.7% | COM | 80706P103 |
| ANNX | ANNEXON INC | 14,549,768 (+44.8%) | $80.61M (+59.8%) | 5.3% | $8.54 | -32.7% | COM | 03589W102 |
| ALXO | ALX ONCOLOGY HLDGS INC | 7,964,188 (+143.9%) | $15.97M (+332.8%) | 1.1% | $7.38 | -76.0% | COM | 00166B105 |
| XENE | XENON PHARMACEUTICALS INC | 262,674 (+96.2%) | $15.27M (+154.5%) | 1.0% | $41.99 | -0.0% | COM | 98420N105 |
| STOK | STOKE THERAPEUTICS INC | 4,164,120 (+3.2%) | $136M (+5.9%) | 9.0% | $9.71 | +227.8% | COM | 86150R107 |
| SLDB | SOLID BIOSCIENCES INC | 2,011,895 (+8.1%) | $14.49M (+38.0%) | 1.0% | $4.76 | +27.2% | COM NEW | 83422E204 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RAPT | RAPT THERAPEUTICS INC | 885,927 | $30.01M | 2.0% | $16.44 | +207.2% | — | 75382E208 |
| REPL | REPLIMUNE GROUP INC | 1,099,756 | $10.69M | 0.7% | $12.40 | -37.1% | — | 76029N106 |
| — | REPARE THERAPEUTICS INC | 1,586,174 | $4.124M | 0.3% | $30.51 | — | — | 760273102 |
| KLRS | KALARIS THERAPEUTICS INC | 82,955 | $700K | 0.0% | $9.79 | -4.3% | — | 482929106 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NRIX | NURIX THERAPEUTICS INC | 7,732,808 (-4.5%) | $120M (-21.9%) | 7.9% | $17.18 | +0.9% | COM | 67080M103 |
| COGT | COGENT BIOSCIENCES INC | 688,036 (-52.2%) | $26.48M (-48.1%) | 1.8% | $9.95 | +275.5% | COM | 19240Q201 |
| IDYA | IDEAYA BIOSCIENCES INC | 521,117 (-29.8%) | $17.36M (-32.3%) | 1.1% | $27.49 | +23.2% | COM | 45166A102 |
| BEAM | BEAM THERAPEUTICS INC | 1,237,659 (-3.7%) | $29.49M (-17.3%) | 2.0% | $26.47 | +10.2% | COM | 07373V105 |
| IVVD | INVIVYD INC | 2,648,659 (-1.2%) | $3.443M (-48.0%) | 0.2% | $16.17 | -87.8% | COM | 00534A102 |
| ADCT | ADC THERAPEUTICS SA | 15,470,502 (-1.3%) | $58.01M (+4.9%) | 3.8% | $19.52 | -80.4% | SHS | H0036K147 |
| CBLL | CERIBELL INC | 386,786 (-11.1%) | $7.09M (-25.7%) | 0.5% | $27.25 | -22.6% | COM | 15678C102 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 103,464 (-8.2%) | $5.875M (-28.5%) | 0.4% | $44.21 | +59.1% | COM | G31249108 |
| ORIC | ORIC PHARMACEUTICALS INC | 415,710 (-7.2%) | $5.267M (+43.7%) | 0.3% | $11.51 | -6.5% | COM | 68622P109 |
| IMNM | IMMUNOME INC | 5,558,885 (-2.8%) | $122M (-1.0%) | 8.1% | $11.49 | +100.8% | COM | 45257U108 |
| PLRX | PLIANT THERAPEUTICS INC | 772,126 (-52.2%) | $973K (-50.7%) | 0.1% | $22.50 | -94.5% | COM | 729139105 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 261,508 (-7.7%) | $8.295M (+7.8%) | 0.5% | $11.60 | +119.2% | COM NEW | 15117B202 |
| LIVN | LIVANOVA PLC | 108,354 (-8.2%) | $6.887M (-5.2%) | 0.5% | $70.40 | -7.5% | SHS | G5509L101 |
| DBVT | DBV TECHNOLOGIES S A | 491,340 (-10.6%) | $10.26M (-2.6%) | 0.7% | $19.17 | — | SPONSORED ADS | 23306J309 |
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RGNX | REGENXBIO INC | 4,368,804 | $36.61M | 2.4% | $22.74 | -49.0% | COM | 75901B107 |
| STTK | SHATTUCK LABS INC | 5,539,724 | $35.62M | 2.4% | $32.14 | -87.1% | COM | 82024L103 |
| NUVB | NUVATION BIO INC | 3,153,256 | $13.53M | 0.9% | $10.97 | -43.6% | COM CL A | 67080N101 |
| KRYS | KRYSTAL BIOTECH INC | 673,505 | $174M | 11.5% | $62.38 | +336.7% | COM | 501147102 |
| ATRA | ATARA BIOTHERAPEUTICS INC | 441,701 | $2.089M | 0.1% | $15.04 | -56.2% | COM NEW | 046513206 |
| ABSI | ABSCI CORPORATION | 8,253,316 | $24.76M | 1.6% | $19.01 | -84.2% | COM | 00091E109 |
| FATE | FATE THERAPEUTICS INC | 12,872,946 | $15.45M | 1.0% | $13.12 | -90.8% | COM | 31189P102 |
| SLN | SILENCE THERAPEUTICS PLC | 2,164,777 | $11.41M | 0.8% | $18.53 | — | ADS | 82686Q101 |
| NGNE | NEUROGENE INC | 1,459,599 | $29.43M | 1.9% | $22.00 | -17.5% | COM | 64135M105 |
| ZYME | ZYMEWORKS INC | 491,654 | $12.31M | 0.8% | $7.05 | +231.7% | COM | 98985Y108 |